Form 8-K - Current report:
SEC Accession No. 0001193125-24-134769
Filing Date
2024-05-09
Accepted
2024-05-09 07:37:09
Documents
58
Period of Report
2024-05-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d813742d8k.htm   iXBRL 8-K 26669
2 EX-99.1 d813742dex991.htm EX-99.1 100058
3 EX-99.2 d813742dex992.htm EX-99.2 46916
7 GRAPHIC g813742ex99_2p10g1.jpg GRAPHIC 258381
8 GRAPHIC g813742ex99_2p11g1.jpg GRAPHIC 204335
9 GRAPHIC g813742ex99_2p12g1.jpg GRAPHIC 219368
10 GRAPHIC g813742ex99_2p13g1.jpg GRAPHIC 182390
11 GRAPHIC g813742ex99_2p14g1.jpg GRAPHIC 139632
12 GRAPHIC g813742ex99_2p15g1.jpg GRAPHIC 218741
13 GRAPHIC g813742ex99_2p16g1.jpg GRAPHIC 202405
14 GRAPHIC g813742ex99_2p17g1.jpg GRAPHIC 241086
15 GRAPHIC g813742ex99_2p18g1.jpg GRAPHIC 212837
16 GRAPHIC g813742ex99_2p19g1.jpg GRAPHIC 130937
17 GRAPHIC g813742ex99_2p1g1.jpg GRAPHIC 291244
18 GRAPHIC g813742ex99_2p20g1.jpg GRAPHIC 242374
19 GRAPHIC g813742ex99_2p21g1.jpg GRAPHIC 369837
20 GRAPHIC g813742ex99_2p22g1.jpg GRAPHIC 238071
21 GRAPHIC g813742ex99_2p23g1.jpg GRAPHIC 303542
22 GRAPHIC g813742ex99_2p24g1.jpg GRAPHIC 190184
23 GRAPHIC g813742ex99_2p25g1.jpg GRAPHIC 246654
24 GRAPHIC g813742ex99_2p26g1.jpg GRAPHIC 212743
25 GRAPHIC g813742ex99_2p27g1.jpg GRAPHIC 148777
26 GRAPHIC g813742ex99_2p28g1.jpg GRAPHIC 258528
27 GRAPHIC g813742ex99_2p29g1.jpg GRAPHIC 249595
28 GRAPHIC g813742ex99_2p2g1.jpg GRAPHIC 383673
29 GRAPHIC g813742ex99_2p30g1.jpg GRAPHIC 163124
30 GRAPHIC g813742ex99_2p31g1.jpg GRAPHIC 244648
31 GRAPHIC g813742ex99_2p32g1.jpg GRAPHIC 266427
32 GRAPHIC g813742ex99_2p33g1.jpg GRAPHIC 228993
33 GRAPHIC g813742ex99_2p34g1.jpg GRAPHIC 221147
34 GRAPHIC g813742ex99_2p35g1.jpg GRAPHIC 157138
35 GRAPHIC g813742ex99_2p36g1.jpg GRAPHIC 250182
36 GRAPHIC g813742ex99_2p37g1.jpg GRAPHIC 296080
37 GRAPHIC g813742ex99_2p38g1.jpg GRAPHIC 207501
38 GRAPHIC g813742ex99_2p39g1.jpg GRAPHIC 114903
39 GRAPHIC g813742ex99_2p3g1.jpg GRAPHIC 272012
40 GRAPHIC g813742ex99_2p40g1.jpg GRAPHIC 259904
41 GRAPHIC g813742ex99_2p41g1.jpg GRAPHIC 261374
42 GRAPHIC g813742ex99_2p42g1.jpg GRAPHIC 182867
43 GRAPHIC g813742ex99_2p4g1.jpg GRAPHIC 350073
44 GRAPHIC g813742ex99_2p5g1.jpg GRAPHIC 268424
45 GRAPHIC g813742ex99_2p6g1.jpg GRAPHIC 229753
46 GRAPHIC g813742ex99_2p7g1.jpg GRAPHIC 268478
47 GRAPHIC g813742ex99_2p8g1.jpg GRAPHIC 157319
48 GRAPHIC g813742ex99_2p9g1.jpg GRAPHIC 268461
49 GRAPHIC g813742g63h16.jpg GRAPHIC 7298
  Complete submission text file 0001193125-24-134769.txt   13863052

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA wve-20240509.xsd EX-101.SCH 2825
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE wve-20240509_lab.xml EX-101.LAB 17925
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE wve-20240509_pre.xml EX-101.PRE 11221
61 EXTRACTED XBRL INSTANCE DOCUMENT d813742d8k_htm.xml XML 3612
Mailing Address 733 CONCORD AVENUE CAMBRIDGE MA 02138
Business Address 7 STRAITS VIEW #12-00, MARINA ONE EAST TOWER SINGAPORE U0 018936 617-949-2900
Wave Life Sciences Ltd. (Filer) CIK: 0001631574 (see all company filings)

EIN.: 000000000 | State of Incorp.: U0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37627 | Film No.: 24928607
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)